Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrani Sarkar

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 14, 2012
Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholaminesChandrani Sarkar, Debanjan Chakroborty, Sujit Basu
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2020
Catecholamines in the regulation of angiogenesis in cutaneous wound healingDebanjan Chakroborty, Sandeep Goswami, Sujit Basu, et al.
Cancers|August 27, 2020
Angiogenesis Inhibition in Prostate Cancer: An UpdateChandrani Sarkar, Sandeep Goswami, Sujit Basu, et al.
International Journal of Cancer|January 6, 2015
Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropeniaChandrani Sarkar, Debanjan Chakroborty, Partha Sarathi Dasgupta, et al.
Angiogenesis|November 18, 2016
Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesisChandrani Sarkar, Ramesh K Ganju, Vincent J Pompili, et al.
Brain, Behavior, and Immunity|November 10, 2009
The immunoregulatory role of dopamine: an updateChandrani Sarkar, Biswarup Basu, Debanjan Chakroborty, et al.
Cancer Health Disparities|February 13, 2023
Racial differences in prostate tumor microenvironment: implications for disparate clinical outcomes and potential opportunitiesSandeep Goswami, Chandrani Sarkar, Seema Singh, et al.
Cancer Research|April 23, 2009
Catecholamines regulate tumor angiogenesisDebanjan Chakroborty, Chandrani Sarkar, Biswarup Basu, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 26, 2019
Facile synthesis of carbon fiber reinforced polymer-hydroxyapatite ternary composite: A mechanically strong bioactive bone graftChandrani Sarkar, Sumanta Kumar Sahu, Arvind Sinha, et al.
Journal of Cell Science|May 20, 2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 14, 2012
Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholaminesChandrani Sarkar, Debanjan Chakroborty, Sujit Basu
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2020
Catecholamines in the regulation of angiogenesis in cutaneous wound healingDebanjan Chakroborty, Sandeep Goswami, Sujit Basu, et al.
Cancers|August 27, 2020
Angiogenesis Inhibition in Prostate Cancer: An UpdateChandrani Sarkar, Sandeep Goswami, Sujit Basu, et al.
International Journal of Cancer|January 6, 2015
Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropeniaChandrani Sarkar, Debanjan Chakroborty, Partha Sarathi Dasgupta, et al.
Angiogenesis|November 18, 2016
Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesisChandrani Sarkar, Ramesh K Ganju, Vincent J Pompili, et al.
Brain, Behavior, and Immunity|November 10, 2009
The immunoregulatory role of dopamine: an updateChandrani Sarkar, Biswarup Basu, Debanjan Chakroborty, et al.
Cancer Health Disparities|February 13, 2023
Racial differences in prostate tumor microenvironment: implications for disparate clinical outcomes and potential opportunitiesSandeep Goswami, Chandrani Sarkar, Seema Singh, et al.
Cancer Research|April 23, 2009
Catecholamines regulate tumor angiogenesisDebanjan Chakroborty, Chandrani Sarkar, Biswarup Basu, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 26, 2019
Facile synthesis of carbon fiber reinforced polymer-hydroxyapatite ternary composite: A mechanically strong bioactive bone graftChandrani Sarkar, Sumanta Kumar Sahu, Arvind Sinha, et al.
Journal of Cell Science|May 20, 2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami, et al.
Pageof 3